ECM-based materials in cardiovascular applications: Inherent healing potential and augmentation of native regenerative processes

International Journal of Molecular Sciences

Volumn 10, Issue 10, 2009, Pages 4375-4417

  Piterina, Anna V ^a   Cloonan, Aidan J ^a   Meaney, Claire L ^a   Davis, Laura M ^a   Callanan, Anthony ^a   Walsh, Michael T ^a   McGloughlin, Tim M ^a  

^a UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Extracellular matrix; Healing; Native regenerative processes; Vascular graft

Indexed keywords

FIBRONECTIN; GAMMA INTERFERON; INTERLEUKIN 4; LAMININ; SCLEROPROTEIN; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 5; VERY LATE ACTIVATION ANTIGEN 6; VITRONECTIN RECEPTOR;

ANTIBIOTIC RESISTANCE; BIOENERGY; BIOMECHANICS; BLOOD VESSEL GRAFT; BLOOD VESSEL INNERVATION; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; GRAFT INFECTION; HUMAN; IMMUNE RESPONSE; IMPLANT; INFECTION RESISTANCE; MECHANOTRANSDUCTION; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE ACTIVATION; TISSUE ENGINEERING; TISSUE REGENERATION; VASCULAR TISSUE; WOUND HEALING;

EXTRACELLULAR MATRIX; HEALING; NATIVE REGENERATIVE PROCESSES; VASCULAR GRAFT;

BACTERIA; BIOCOMPATIBLE MATERIALS; BLOOD VESSELS; EXTRACELLULAR MATRIX; HUMANS; PROSTHESES AND IMPLANTS; REGENERATION; TISSUE ENGINEERING; WOUND HEALING;

BACTERIA (MICROORGANISMS);

EID: 71649099103     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms10104375     Document Type: Review

References (304)

1. Vascular Surgery: Principals and Practice; Hobson, R.W., Wilson, S.E., Veith, F.J., Eds.; McGraw-Hill: New York, NY, USA, 2003.
2. Vascular Graft Update, ASTM STP 898; Kambic, H.E., Kantrowitz, A., Sung, P., Eds.; American Society for Testing and Materials International: Philadelphia, PA, USA, 1986.
3. Bezuidenhout, D.; Zilla, P. Vascular grafts. In Encyclopedia of Biomaterials and Biomedical Engineering; Wnek, G.E., Bowlin, G.L., Eds.; Informa Health Care: New York, NY, USA, 2008.
4. Davis, L.; Dower, T.; Zilla, P. The lack of healing in conventional vascular grafts. In Tissue Engineering of Vascular Prosthetic Grafts; Zilla, P., Greisler, H.P., Eds.; Landes Company: Austin, TX, USA, 1999; pp. 3-44.
5. Greisler, H.P. Characteristics and healing of vascular grafts. In Vascular Surgery: Theory and Practice; Callow, A.D., Ernst, C.B., Eds.; Appleton & Lange: Stamford (Conn), New York, NY, USA, 1995; pp. 1181-1212.
6. Anderson, M. Procedures in the retrieval and evaluation of vascular grafts. In Vascular Graft Update: Safety and Performance; Kambic, H.E., Kantrowitz, A., Sung, P., Eds.; American Society for Testing and Materials: Philadelphia, Pennsylvania, USA, 1986; pp. 156-165.
7. Clowes, W.; Gown, A.M.; Hanson, S.R.; Reidy, M.A. Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. Amer. J. Pathol. 1985, 118, 43-54.
8. Clowes, A.W.; Kinkman, T.R.; Reidy, M.A. Mechanisms of arterial graft healing. A rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses. Amer. J. Pathol. 1986, 123, 220-230.
9. Burkel, W.E. The development of cellular linings in artificial vascular prostheses. In Biocompatible Polymers, Metals and Composites; Szycher, M., Ed.; Technomic Publ. Co., Inc.: Lancaster, PA, USA, 1983; pp. 165-178.
10. Nanotechnology and Tissue Engineering: The scaffold; Laurencin, C.T., Nair, L., Eds.; CRC Press: New York, NY, USA, 2008.
11. Ratner, B.D.; Hoffman, A.S.; Schoen, F.J.; Lemons, J.E. Biomaterials Science: An Introduction to Materials and Medicine, 2nd ed.; Elsevier: Oxford, UK, 2004.
12. Biomaterials Engineering and Devices: Fundamentals and Vascular and Carrier Applications; Wise, D.L., Ed.; Humana Press: Totowa, NJ, USA, 2000.
13. Functional Materials and Biomaterials; Liu, X.D., Ed.; Springer: Berlin, Germany, 2007.
14. Szycher, M. Blood compatibility and vascular prostheses. In High Performance Biomaterials: A Complete Guide to Medical and Pharmceutical Applications; Szycher, M., Ed.; CRC Press LLC: Boca Raton, FL, USA, 1991.
15. Inayat-Hussain, S. and Rajab, N.F. In vitro testing of biomaterial toxicity and biocompatibility. In Cellular Response to Biomaterials; Di Silvio, L., Ed.; Woodhead Publishing Ltd: Cambridge, UK, 2008.
16. Fortunato, J.E.; Glagov, S.; Bassiouny, H.S. Biomechanical factors as regulators of biological responses to vascular grafts. Semin. Vasc. Surg. 1999, 12, 27-37.
17. Badylak, S.F.; Freytes, D.O.; Gilbert, T.W. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater. 2009, 5, 1-13.
18. Gilbert, T.W.; Sellaro, T.L.; Badylak, S.F. Decellularisation of tissues and organs. Biomaterials 2006, 27, 3675-3683.
19. Sandusky, G.E.; Lantz, G.C.; Badylak, S.F. Healing comparison of small intestine submucosa and ePTFE grafts in the canine carotid artery. J. Surg. Res. 1995, 58, 415-420.
20. Badylak, S.F.; Coffey, A.C.; Lantz, G.C.; Tacker, W.A.; Geddes, L.A. Comparison of the resistance to infection of intestinal submucosa arterial autografts versus polytetrafluoroethylene arterial prostheses in a dog model. J. Vasc. Surg. 1994, 19, 465-472.
21. Prevel, C.D.; Eppley, B.L.; McCarty, M.; Jackson, J.R.; Voytik, S.L.; Hiles, M.C.; Badylak, S.F. Experimental evaluation of small intestinal submucosa as a microvascular graft material. Microsurgery 1994, 15, 586-591.
22. Lantz, G.C.; Badylak, S.F.; Hiles, M.C.; Coffey, A.C.; Geddes, L.A.; Kokini, K.; Sandusky, G.E.; Morff, R.J. Small intestinal submucosa as a vascular graft: A review. J. Invest. Surg. 1993, 6, 297-310.
23. Hiles, M.C.; Badylak, S.F.; Geddes, L.A.; Kokini, K.; Morff, R.J. Porosity of porcine smallintestinal submucosa for use as a vascular graft. J. Biomed. Mater. Res. 1993, 27, 139-144.
24. Lantz, G.C.; Badylak, S.F.; Coffey, A.C.; Geddes, L.A.; Sandusky, G.E. Small intestinal submucosa as a superior vena cava graft in the dog. J. Surg. Res. 1992, 53, 175-181.
25. Badylak, S.F.; Lantz, G.C.; Coffey, A.; Geddes, L.A. Small intestinal submucosa as a large diameter vascular graft in the dog. J. Surg. Res. 1989, 47, 74-80.
26. Prasertsung, I.; Kanokpanont, S.; Bunaprasert, T.; Thanakit, V.; Damrongsakkul, S. Development of acellular dermis from porcine skin using periodic pressurized technique. J Biomed. Mater. Res. B Appl. Biomater. 2008, 85, 210-219.
27. Mirsch, M.W., II; Schroeder, R.F.B.; Illingworth B.; Borner, W.H.; Montoya, S.I. Use of microorganisms for decellularizing bioprosthetic tissue. 2000, US Patent 6121041.
28. Rashid, S.T.; Salacinski, H.J.; Hamilton, G.; Seifalian, A.M. The use of animal models in developing the discipline of cardiovascular tissue engineering: A review. Biomaterials 2004, 25, 1627-1637. (Pubitemid 38091541)
29. Schmidt, C.E.; Baier, J.M. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000, 21, 2215-2231.
30. Lü, W.D.; Zhang, M.; Wu, Z.S.; Hu, T.H. Decellularized and photooxidatively crosslinked bovine jugular veins as potential tissue engineering scaffolds. Interact. CardioVasc. Thorac. Surg. 2009, 8, 301-305.
31. Derham, C.; Yow, H.; Ingram, J.; Fisher, J.; Ingham, E.; Korrosis, S.A.; Homer-Vanniasinkam, S. Tissue engineering small-diameter vascular grafts: Preparation of a biocompatible porcine ureteric scaffold. Tissue Eng. Part A 2008, 14, 1871-1882.
32. Wilshaw, S.P.; Kearney, J.; Fisher, J.; Ingham, E. Biocompatibility and potential of acellular human amniotic membrane to support the attachment and proliferation of allogeneic cells. Tissue Eng. Part A 2008, 14, 463-472.
33. Nyland, J.; Larsen, N.; Burden, R.; Chang, H.; Caborn, D.N. Biomechanical and tissue handling property comparison of decellularized and cryopreserved tibialis anterior tendons following extreme incubation and rehydration. Knee Surg. Sports Traumatol. Arthrosc. 2009, 17, 83-91.
34. Weadock, K.; Olson, R.M.; Silver, F.H. Evaluation of collagen crosslinking techniques. Biomater. Med. Devices Artif. Organs 1983, 11, 293-318.
35. Sacks, M.S.; Hamamoto, H.; Connolly, J.M.; Gorman, R.C.; Gorman, J.H., III; Levy, R.J. In vivo biomechanical assessment of triglycidylamine crosslinked pericardium. Biomaterials 2007, 28, 5390-5398.
36. Garcia, Y.; Hemantkumar, N.; Collighan, R.; Griffin, M.; Rodriguez-Cabello, J.C.; Pandit, A. In vitro characterization of a collagen scaffold enzymatically cross-linked with a tailored elastinlike polymer. Tissue Eng. Part A 2009, 15, 887-899.
37. Somers, P.; De Somer, F.; Cornelissen, M.; Bouchez, S.; Gasthuys, F.; Narine, K.; Cox, E.; van Nooten, G. Genipin blues: An alternative non-toxic crosslinker for heart valves? J. Heart Valve Dis. 2008, 17, 682-688.
38. Freytes, D.O.; Martin, J.; Velankar, S.S.; Lee, A.S.; Badylak, S.F. Preparation and rheological characterization of a gel form of the porcine urinary bladder matrix. Biomaterials 2008, 29, 1630-1637.
39. Brockbank, K.G.; MacLellan, W.R. Optimized preservation of extracellular matrix in cardiac tissues: Implications for long-term graft durability. Ann. Thorac. Surg. 2007, 83, 1641-1650.
40. Freytes, D.O.; Tullius, R.S.; Valentinm, J.E.; Stewart-Akers, A.M.; Badylak, S.F. Hydrated versus lyophilized forms of porcine extracellular matrix derived from the urinary bladder. J Biomed. Mater. Res. A. 2008, 87, 862-872.
41. Piterina, A.V.; Davis, L.M; Meaney, C.L; Walsh, M.T.; Badylak, S.F.; McGloughlin, T.M. Characterisation of structural features a full-thickness acellular matrices deriving from animal organs. In Proceedings of Bioengineering in Ireland 15, Jan 30-31, Limerick, Ireland, 2009.
42. Piterina, A.V.; Callanan, A.; Davis, L.M; Meaney, C.L; Walsh, M.T.; McGloughlin, T.M. ECM matrices as an advanced scaffold for vascular tissue engineering. Bio.-Med. Mater. Eng. 2009, in press.
43. Piterina, A.V.; Davis, L.M.; Meaney, C.L.; Cloonan, A.J.; Walsh, M.T.; McGloughlin, T.M.; Cell-seeded decellularised extracellular matrices as an advanced approach for tissue engineering. In Proceedings of International Conference on Tissue Engineering ICTE, Leiria, Portugal, July 9-11, 2009
44. Brown, B.; Lindberg, K.; Reing, J.; Stolz, D.B.; Badylak, S.F. The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng. 2006, 12, 519-526.
45. Hodde, J.; Record, R.; Tullius, R.; Badylak, S. Fibronectin peptides mediate HMEC adhesion to porcine-derived extracellular matrix. Biomaterials 2002, 23, 1841-1848. (Pubitemid 34218971)
46. Hodde, J.P.; Record, R.D.; Liang, H.A.; Badylak, S.F. Vascular endothelial growth factor in porcine-derived extracellular matrix. Endothelium 2001, 8, 11-24. (Pubitemid 32454574)
47. Helton, W.S.; Fisichella, P.M.; Berger, R.; Horgan, S.; Espat, N.J.; Abcarian, H. Short-term outcomes with small intestinal submucosa for ventral abdominal hernia. Arch. Surg. 2005, 140, 549-562. (Pubitemid 40965058)
48. Badylak, S.F.; Vorp, D.A.; Spievack, A.R.; Simmons-Byrd, A.; Hanke, J.; Freytes, D.O.; Thapa, A.; Gilbert, T.W.; Nieponice, A. Esophageal reconstruction with ECM and muscle tissue in a dog model. J. Surg. Res. 2005, 128, 87-97. (Pubitemid 41188215)
49. Rosalia, M.; Mark, P.C.; Anthony, J.C.; Martin, K.; Kirstan, K.M.; Richard, C.R. Small intestinal submucosa bladder neck slings for incontinence associated with neuropathic bladder. J. Urology 2005, 174, 1680-1682. (Pubitemid 41318659)
50. Malcarney, H.L.; Bonar, F.; Murrell, G.A.C. Early Inflammatory reaction after rotator cuff repair with a porcine small intestine submucosal implant. Am. J. Sport Med. 2005, 33, 907-911.
51. El-Assmy, A.; Hafez, A.T.; El-Sherbiny, M.T.; El-Hamid, M.A.; Mohsen, T.; Nour, E.M.; Bazeed, M. Use of single layer small intestinal submucosa for long segment ureteral replacement: A pilot study. J. Urology 2004, 171, 1939-1942. (Pubitemid 38501048)
52. De Ugarte, D.A.; Choi, E.; Weitzbuch, H.; Wulur, I.; Caulkins, C.; Wu, B.; Fonkalsrud, E.W.; Atkinson, J.B.; Dunn, J.C.Y. Mucosal regeneration of a duodenal defect using small intestine submucosa. Am. Surgeon 2004, 70, 49-51.
53. Jones, J.S.; Rackley, R.R.; Berglund, R.; Abdelmalak, J.B.; Deorco, G.; Vasavada, S.P. Porcine small intestinal submucosa as a percutaneous mid-urethral sling: 2-year results. BJU Int. 2005, 96, 103-106.
54. Ziats, N.P.; Miller, K.M.; Anderson, J.M. In vitro and in vivo interactions of cells with biomaterials. Biomaterials 1988, 9, 5-13. (Pubitemid 18035328)
55. Tang, L.; Ugarova, T.P.; Plow, E.F.; Eaton, J.W. Molecular determinants of acute inflammatory responses to biomaterials. J. Clin. Invest. 1996, 97, 1329-1334. (Pubitemid 26085490)
56. Anderson, J.M.; Rodriguez, A.; Chang, D.T. Foreign body reaction to biomaterials. Semin. Immunol. 2008, 20, 86-100.
57. Janatova, J. Activation and control of complement, inflammation, and infection associated with the use of biomedical polymers. ASAIO J. 2000, 46, 53-62.
58. Xia, Z.; Triffitt, J.T. A review on macrophage responses to biomaterials. Biomed. Mater. 2006, 1, 1-9.
59. Anderson, J.M.; Miller, K.M. Biomaterial biocompatibility and the macrophage. Biomaterials 1984, 5, 5-10.
60. Valentin, J.E.; Stewart-Akers, A.M.; Gilbert, T.W.; Badylak, S.F. Macrophage participation in the degradation and remodeling of ECM scaffolds. Tissue Eng. Part A 2009, 15, in press.
61. Mensik, A.; Brouwer, A.; van den Burg, E.H.; Geurts, S.; Jongen, W.M.F.; Lakemond, C.M.M.; Meijerman, I.; van der Wijk, T. Modulation of intercellular communication between smooth muscle cells by growth factors and cytokines. Eur. J. Pharmacol. 1996, 310, 73-81. (Pubitemid 26284259)
62. Mills, D.; Kincaid, K.; Alt, J.M.; Heilman, M.J.; Hill, A.M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 2000, 164, 6166-6173.
63. Badylak, S.F.; Gilbert, T.W. Immune response to biologic scaffold materials. Semin. Immunol. 2008, 20, 109-116.
64. Rehman, J.; Li, J.; Orschell, C.M.; March, K.L. Peripheral blood 'endothelial progenitor cells' are derived from monocyte/ macrophages and secrete angiogenic growth factors. Circulation 2003, 107, 1164-1169.
65. Palmer, E.M.; Beilfuss, B.A.; Nagai, T.; Semnani, R.T.; Badylak, S.F.; van Seventer, G.A. Human helper T cell activation and differentiation is suppressed by porcine small intestinal submucosa. Tissue Eng. 2002, 8, 893-900.
66. Allman, A.J.; McPherson, T.B.; Merrill, L.C.; Badylak, S.F.; Metzger, D.W. The Th2-restricted immune response to xenogeneic small intestinal submucosa does not influence systemic protective immunity to viral and bacterial pathogens. Tissue Eng. 2002, 8, 53-62.
67. Brodbeck, W.G.; Voskerician, G.; Ziats, N.P.; Nakayama, Y.; Matsuda, T.; Anderson, J.M. In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. J. Biomed. Mater. Res. A 2003, 64, 320-329.
68. Zetrenne, E.; McIntosh, B.C.; McRae, M.H.; Gusberg, R.; Evans, G.R.; Narayan, D. Prosthetic vascular graft infection: A multi-center review of surgical management. Yale J. Biol. Med. 2007, 80, 113-121.
69. Chiesa, R.; Astore, D.; Frigerio, S.; Garriboli, L.; Piccolo, G.; Castellano, R.; Scalamogna, M.; Odero, A.; Pirrelli, S.; Biasi, G.; Mingazzini, P.; Biglioli, P.; Polvani, G.; Guarino, A.; Agrifoglio, G.; Tori, A.; Spina, G. Vascular prosthetic graft infection: Epidemiology, bacteriology, pathogenesis and treatment. Acta Chir. Belg. 2002, 102, 238-247.
70. Mertens, R.A.; O'Hara, P.J.; Hertzer, N.R.; Krajewski, L.P.; Beven, E.G. Surgical management of infrainguinal arterial prosthetic graft infections: Review of a 35-year experience. J. Vasc. Surg. 1995, 21, 782-791.
71. Bunt, T.J. Vascular graft infections: An update. Cardiovasc. Surg. 2001, 9, 225-233.
72. Mermel, L.A.; Farr, B.M.; Sheretz, R.J.; Raad, I.I.; O'Grady, N.; Harris, J.S.; Craven, D.E. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 2001, 32, 1249-1272. (Pubitemid 32405897)
73. Perera, G.B.; Fujitani, R.M.; Kubaska, S.M. Aortic graft infection: Update on management and treatment options. Vasc. Endovasc. Surg. 2006, 40, 1-10.
74. Sharp, W.J.; Hoballah, J.J.; Mohan, C.R.; Kresowik, T.F.; Martinasevic, M.; Chalmers, R.T.A.; Corson, J.D. The management of the infected aortic prosthesis: A current decade of experience. J. Vasc. Surg. 1994, 19, 844-850.
75. Swain, T.W., III; Calligaro, K.D.; Dougherty, M.D. Management of infected aortic prosthetic grafts. Vasc. Endovasc. Surg. 2004, 38, 75-82.
76. Padberg, F.T., Jr.; Calligaro, K.D.; Sidawy, A.N. Complications of arteriovenous hemodialysis access: Recognition and management. J. Vasc. Surg. 2008, 48, S55-S80.
77. Holland, F.W.; Darling, R.C., III; Chang, B.B.; Shah, D.M.; Leather, R.P. Clostridial aortic graft infection. Ann. Vasc. Surg. 1994, 8, 387-389.
78. Upchurch, G.R., Jr.; Clair, D.G.; Whittemore, A.D.; Mannick, J.A. Clostridium septicum bacteremia associated with aortic graft infection. J. Vasc. Surg. 1995, 22, 493-495.
79. Lephart, P.; Ferrieri, P.; van Burik, J.A. Reservoir of Candida albicans infection in a vascular bypass graft demonstrates a stable karyotype over six months. Med. Mycol. 2004, 42, 255-260.
80. van Dijk, J.; Herkströter, F.; Busscher, H.; Weerkamp, A.; Jansen, H.; Arends, J. Surface-free energy and bacterial adhesion. An in vivo study in beagle dogs. J. Clin. Periodontol. 1987, 14, 300-304.
81. Wadström, T. Molecular aspects of bacterial adhesion, colonization, and development of infections associated with biomaterials. J. Invest. Surg. 1989, 2, 353-360. (Pubitemid 20143844)
82. Fleer, A.; Verhoef, J. An evaluation of the role of surface hydrophobicity and extracellular slime in the pathogenesis of foreign-body-related infections due to coagulase-negative staphylococci. J. Invest. Surg. 1989, 2, 391-396. (Pubitemid 20143847)
83. Jansen, B.; Schumacher-Perdreau, F.; Peters, G.; Pulverer, G. New aspects in the pathogenesis and prevention of polymer-associated foreign-body infections caused by coagulase-negative staphylococci. J. Invest. Surg. 1989, 2, 361-380. (Pubitemid 20143845)
84. Hussain, M.; Wilcox, M.H.; White, P.J. The slime of coagulase-negative staphylococci: Biochemistry and relation to adherence. FEMS Microbiol. Rev. 1993, 10, 191-207. (Pubitemid 223031403)
85. Baselga, R.; Albizu, I.; De La Cruz, M.; Del Cacho, E.; Barberan, M.; Amorena, B. Phase variation of slime production in Staphylococcus aureus: Implications in colonization and virulence. Infect. Immun. 1993, 61, 4857-4862. (Pubitemid 23320545)
86. Christensen, G.D.; Simpson, W.A.; Bisno, A.L.; Beachey, E.H. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect. Immun. 1982, 37, 318-326.
87. Kristinsson, K.G.; Spencer, R.C. Slime production as a marker for clinically significant infections with coagulase-negative staphylococci. J. Infect. Dis. 1986, 154, 728-729.
88. Gross, M.; Cramton, S.E.; Gotz, F.; Peschel, A. Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect. Immun. 2001, 69, 3423-3426. (Pubitemid 32332242)
89. Treiman, G.S.; Copland, S.; Yellin, A.E.; Lawrence, P.F.; McNamara, R.M.; Treiman, R.L. Wound infections involving infrainguinal autogenous vein grafts: A current evaluation of factors determining successful graft preservation. J. Vasc. Surg. 2001, 33, 948-954.
90. Donlan, R.M.; Costerton, J.W. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002, 15, 167-193.
91. Gilbert, P.; Maira-Litran, T.; McBain, A.J.; Rickard, A.H.; Whyte, F.W. The physiology and collective recalcitrance of microbial biofilm communities. Adv. Microb. Physiol. 2002, 46, 202-256.
92. Ito, A.; Taniuchi, A.; May, T.; Kawata, K.; Okabe, S. Increased antibiotic resistance of Escherichia coli in mature biofilms. Appl. Environ. Microbiol. 2009, 75, 4093-4100.
93. Aslam, S. Effect of antibacterials on biofilms. Am. J. Infect. Control. 2008, 36, S175e9-175e11.
94. Simões, M.; Simões, L.C.; Vieira, M.J. Species association increases biofilm resistance to chemical and mechanical treatments. Water Res. 2009, 43, 229-237.
95. Anderson, G.G.; O'Toole, G.A. Innate and induced resistance mechanisms of bacterial biofilms. Curr. Top. Microbiol. Immunol. 2008, 322, 85-105.
96. Lewis, K. Multidrug tolerance of biofilms and persister cells. Curr. Top. Microbiol. Immunol. 2008, 322, 107-131.
97. Dofferhoff, A.S.; Nijland, J.H.; de Vries-Hospers, H.G.; Mulder, P.O.; Weits, J.; Bom, V.J. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: An in-vitro and in-vivo study. Scand. J. Infect. Dis. 1991, 23, 745-754.
98. Prins, J.M.; van Deventer, S.J.; Kuijper, E.J.; Speelman, P. Clinical relevance of antibioticinduced endotoxin release. Antimicrob. Agents Ch. 1994, 38, 1211-1218. (Pubitemid 24170697)
99. Kirikae, T.; Nakano, M.; Morrison, D.C. Antibiotic-induced endotoxin release from bacteria and its clinical significance. Microbiol. Immunol. 1997, 41, 285-294.
100. Hurley, J.C. Antibiotic-induced release of endotoxin: A reappraisal. Clin. Infect. Dis. 1992, 15, 840-854.
101. Nau, R.; Eiffert, H. Minimizing the release of proinflammatory and toxic bacterial products within the host: A promising approach to improve outcome in life-threatening infections. FEMS Immunol. Med. Microbiol. 2005, 44, 1-16. (Pubitemid 40380897)
102. Nagase, H.; Woessner, F. Matrix metalloproteinases. J. Biol. Chem. 1999, 274, 21491-21494.
103. Young, R.M.; Cherry, K.J., Jr.; Davis, P.M.; Gloviczki, P.; Bower, T.C.; Panneton, J.M.; Hallett, J.W., Jr. The results of in situ prosthetic replacement for infected aortic grafts. Am. J. Surg. 1999, 178, 136-140.
104. Wilson, S.E. New alternatives in management of the infected vascular prosthesis. Surg. Infect. 2001, 2, 171-177.
105. Greco, R.S.; Harvey, R.A.; Smilow, P.C.; Tesoriero, J.V. Prevention of vascular prosthetic infection by a benzalkonium-oxacillin bonded polytetrafluoroethylene graft. Surg. Gyn. Obstet. 1982, 155, 28-32. (Pubitemid 12089355)
106. Sobinsky, K.R.; Flanigan, P. Antibiotic binding to polytetrafluoroethylene via glucosaminoglycan-keratin luminal coating. Surgery 1986, 100, 629-633.
107. Shenk, J.S.; Ney, A.L.; Tsukayama, D.T.; Olson, M.E.; Bubrick, M.P. Tobramycin-adhesive in preventing and treating PTFE vascular graft infections. J. Surg. Res. 1989, 47, 487-492.
108. Ney, A.L.; Kelly, P.H.; Tsukayama, D.T.; Bubrick, M.P. Fibrin glue-antibiotic suspension in the prevention of prosthetic graft infection. J. Trauma 1990, 30, 1000-1006.
109. Haverich, A.; Hirt, S.; Karck, M.; Siclari, F.; Wahlig, H. Prevention of graft infection by bonding of gentamycin to Dacron prostheses. J. Vasc. Surg. 1992, 15, 187-193.
110. Gahtan, V.; Esses, G.E.; Bandyk, D.F.; Nelson, R.T.; Dupont, E.; Mills, J. Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts. J. Surg. Res. 1995, 58, 105-110.
111. Sago, T.; Mori, Y.; Takagi, H.; Iwata, H.; Murase, K.; Kawamura, Y.; Hirose, H. Local treatment of Dacron patch graft contaminated with Staphylococcus aureus with antibiotic-releasing porous apatite ceramic: An experimental study in the rabbit. J. Vasc. Surg. 2003, 37, 169-174. (Pubitemid 36236962)
112. Darouiche, R.O.; Mansouri, M.D. In vitro activity and in vivo efficacy of antimicrobial-coated vascular grafts. Ann. Vasc. Surg. 2004, 18, 497-501. (Pubitemid 39014617)
113. Kinney, E.V.; Bandyk, D.F.; Seabrook, G.A.; Kelly, H.M.; Towne, J.B. Antibiotic-bonded PTFE vascular grafts: The effect of silver antibiotic on bioactivity following implantation. J. Surg. Res. 1991, 50, 430-435.
114. Hernandez-Richter, T.; Schardey, H.M.; Löhlein, F.; Heiss, M.M.; Redondo-Müller, M.; Hammer, C.; Schildberg, F.W. The prevention and treatment of vascular graft infection with a triclosan (Irgasan)-bonded Dacron graft: An experimental study in the pig. Eur. J. Vasc. Endovasc. Surg. 2000, 20, 413-418. (Pubitemid 32051125)
115. Ghiselli, R.; Giacometti, A.; Cirioni, O.; Mocchegiani, F.; Orlando, F.; Kamysz, W.; Del Prete, M.S.; Lukasiak, J.; Scalise, G.; Saba, V. Temporin A as a prophylactic agent against methicillin sodium susceptible and methicillin sodium resistant Staphylococcus epidermidis vascular graft infection. J. Vasc. Surg. 2002, 36, 1027-1030. (Pubitemid 35316080)
116. Ginalska, G.; Kowalczuk, D.; Osinska, M. A chemical method of gentamicin bonding to gelatine-sealed prosthetic vascular grafts. Int. J. Pharm. 2005, 288, 131-140. (Pubitemid 39656461)
117. Ginalska, G.; Osinska, M.; Uryniak, A.; Urbanik-Sypniewska, T.; Belcarz, A.; Rzeski, W.; Wolski, A. Antibacterial activity of gentamicin-bonded gelatin-sealed polyethylene terephtalate vascular prostheses. Eur. J. Vasc. Endovasc. Surg. 2005, 29, 419-424. (Pubitemid 40331379)
118. Sacar, M.; Scar, S.; Kaleli, I.; Onem, G.; Turgut, H.; Goksin, I.; Ozcan, V.; Inan, B.K.; Duver, H.; Baltalari, A. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. J. Surg. Res. 2007, 139, 170-175. (Pubitemid 46551167)
119. Schmacht, D.; Armstrong, P.; Johnson, B.; Pierre, K.; Back, M.; Honeyman, A.; Cuthbertson, D.; Bandyk, D. Graft infectivity of rifampin and silver-bonded polyester grafts to MRSA contamination. Vasc. Endo Surg. 2005, 39, 411-420. (Pubitemid 41446816)
120. Hirose, K.; Marui, A.; Arai, Y.; Nomura, T.; Inoue, S.; Kaneda, K.; Kamitani, T.; Fujita, M.; Mitsuyama, M.; Tabata, Y.; Komeda, M. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection. J. Vasc. Surg. 2006, 44, 377-382. (Pubitemid 44142921)
121. Hardman, S.; Cope, A.; Swann, A.; Bell, P.R.F.; Naylor, A.R.; Hayes, P.D. An in vitro model to compare the antimicrobial activity of silver-coated versus rifampicin-soaked vascular grafts. Ann. Vasc. Surg. 2004, 18, 308-313.
122. Batt, M.; Magne, J.L.; Alric, P.; Muzj, A.; Ruotolo, C.; Ljungstrom, K.G.; Garcia-Casas, R.; Simms, M. In situ revascularization with silver-coated polyester grafts to treat aortic infection: Early and midterm results. J. Vasc. Surg. 2003, 38, 983-989. (Pubitemid 37409632)
123. Ueberrueck, T.; Zippel, R.; Tautenhahn, J.; Gastinger, I.; Lippert, H.; Wahlers, T. Vascular graft infections: In vitro and in vivo investigations of a new vascular graft with long-term protection. J. Biomed. Mater. Res. B Appl. Biomat. 2005, 74, 601-607.
124. Hernandez-Richter, T.; Schardey, H.M.; Wittmann, F.; Mayr, S.; Schmitt-Sody, M.; Blasenbreu, S.; Heiss, M.M.; Gabka, C.; Angele, M.K. Rifampin and triclosan but not silver is effective in preventing bacterial infection of vascular Dacron graft material. Eur. J. Vasc. Endovasc. Surg. 2003, 26, 550-557.
125. Gomez-Lus, R. Evolution of bacterial resistance to antibiotics during the last three decades. Int. Microbiol. 1998, 1, 279-284. (Pubitemid 128731342)
126. Brennan, E.P.; Reing, J.; Chew, D.; Myers-Irvin, J.M.; Young, E.J.; Badylak, S.F. Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix. Tissue Eng. 2006, 12, 2949-2955.
127. Sarikaya, A.; Record, R.; Wu, C.C.; Tullius, B.; Badylak, S.; Ladisch, M. Antimicrobial activity associated with extracellular matrices. Tissue Eng. 2002, 8, 63-71. (Pubitemid 34194665)
128. Badylak, S.F.; Coffey, A.C.; Lantz, G.C.; Tacker, W.A.; Geddes, L.A. Comparison of the resistance to infection of intestinal submucosa arterial autografts versus polytetrafluoroethylene arterial prostheses in a dog model. J. Vasc. Surg. 1994, 19, 465-472.
129. Badylak, S.F.; Wu, C.C.; Bible, M.; McPherson, E. Host protection against deliberate bacterial contamination of an extracellular matrix bioscaffold versus Dacron mesh in a dog model of orthopedic soft tissue repair. J. Biomed. Mater. Res. B Appl. Biomater. 2003, 67, 648-654. (Pubitemid 37517117)
130. Steinstraesser, L.; Koehler, T.; Jacobsen, F.; Daigeler, A.; Goertz, O.; Langer, S.; Kesting, M.;Steinau, H.; Eriksson, E.; Hirsch, T. Host defense peptides in wound healing. Mol. Med. 2008, 14, 528-537.
131. Hirsch, T.; Metzig, M.; Niederbichler, A.; Steinau, H.U.; Eriksson, E.; Steinstraesser, L. Role of host defense peptides of the innate immune response in sepsis. Shock 2008, 30, 117-126.
132. Nuding, S.; Zabel, L.T.; Enders, C.; Porter, E.; Fellermann, K.; Wehkamp, J.; Mueller, H.A.; Stange, E.F. Antibacterial activity of human defensins on anaerobic intestinal bacterial species: A major role of HBD-3. Microbes Infect. 2009, 11, 384-393.
133. Brown, K.L.; Hancock, R.E. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 2006, 18, 24-30. (Pubitemid 43049644)
134. Gallo, R.L.; Murakami, M.; Ohtake, T.; Zaiou, M. Biology and clinical relevance of naturally occurring antimicrobial peptides. J. Allergy Clin. Immunol. 2002, 110, 823-831.
135. Alobaid, N.; Alnaeb, M.E.; Sales, K.M.; Seifalian, A.M.; Mikhailidis, D.P.; Hamilton, G. Endothelial progenitor cells and their potential clinical applications in peripheral arterial disease. Endothelium 2005, 12, 243-250. (Pubitemid 43771808)
136. Miller-Kasprzak, E.; Jagodziński, P.P. Endothelial progenitor cells as a new agent contributing to vascular repair. Arch. Immunol. Ther. Exp. 2007, 55, 247-259. (Pubitemid 47262710)
137. Hristov, M.; Weber, C. Endothelial progenitor cells: Characterization, pathophysiology, and possible clinical relevance. J. Cell Mol. Med. 2004, 8, 498-508 (Pubitemid 44145482)
138. Hristov, M.; Erl, W.; Weber, P.C. Endothelial progenitor cells: Mobilization, differentiation, and homing. Arterioscler Thromb. Vasc. Biol. 2003, 23, 1185-1189. (Pubitemid 36871271)
139. Yasu, T. Differentiation of endothelial progenitor cells. Circ. J. 2009, 73, 1199-1200.
140. Pelliccia, F.; Pasceri, V.; Cianfrocca, C.; Vitale, C.; Pristipino, C.; Speciale, G.; Mercuro, G.; Rosano, G. Endothelial progenitor cells in patients with coronary artery disease and left ventricular dysfunction. Coron. Artery Dis. 2009, in press.
141. Zilla, P.; Bezuidenhout, D.; Human P. Prosthetic vascular grafts: Wrong models, wrong questions and no healing. Biomaterial 2007, 28, 5009-5027. (Pubitemid 47489794)
142. Bordenave, L.; Fernandez, P.; Rémy-Zolghadri, M.; Villars, S.; Daculsi, R.; Midy, D. In vitro endothelialized ePTFE prostheses: Clinical update 20 years after the first realization. Clin .Hemorheol. Microcirc. 2005, 33, 227-234. (Pubitemid 41433857)
143. Bhat, V.D.; Klitzman, B.; Koger, K.; Truskey, G.A.; Reichert, W.M. Improving endothelial cell adhesion to vascular graft surfaces: Clinical need and strategies. J. Biomater. Sci. Polym. Ed. 1998, 9, 1117-1135.
144. Xiao, L.; Shi, D. Role of precoating in artificial vessel endothelialization. Chin. J. Traumatol. 2004, 7, 312-316. (Pubitemid 39317482)
145. Salacinski, H.J.; Tiwari, A.; Hamilton, G.; Seifalian, A.M. Cellular engineering of vascular bypass grafts: Role of chemical coatings for enhancing endothelial cell attachment. Med. Biol. Eng. Comput. 2001, 39, 609-618.
146. Shaikh, F.M.; Callanan, A.; Kavanagh, E.G.; Burke, P.E.; Grace, P.A.; McGloughlin, T.M. Fibrin: A natural biodegradable scaffold in vascular tissue engineering. Cells Tissues Organs 2008, 188, 333-346.
147. Alobaid, N.; Salacinski, H.J.; Sales, K.M.; Hamilton, G.; Seifalian, A.M. Single stage cell seeding of small diameter prosthetic cardiovascular grafts. Clin. Hemorheol. Microcirc. 2005, 33, 209-226.
148. Walluscheck, K.P.; Steinhoff, G.; Haverich, A. Endothelial cell seeding of de-endothelialised human arteries: Improvement by adhesion molecule induction and flow-seeding technology. Eur. J. Vasc. Endovasc. Surg. 1996, 12, 46-53. (Pubitemid 26261556)
149. Walluscheck, K.P.; Steinhoff, G.; Haverich, A. Endothelial cell seeding of native vascular surfaces. Eur. J. Vasc. Endovasc. Surg. 1996, 11, 290-303. (Pubitemid 26128886)
150. Bordenave, L.; Rémy-Zolghadri, M.; Fernandez, P.; Bareille, R.; Midy, D. Clinical performance of vascular grafts lined with endothelial cells. Endothelium 1999, 6, 267-275. (Pubitemid 29364173)
151. Falk, J.; Townsend, L.E.; Vogel, L.M.; Boyer, M.; Olt, S.; Wease, G.L.; Trevor, K.T.; Seymour, M.; Glover, J.L.; Bendick, P.J. Improved adherence of genetically modified endothelial cells to small-diameter expanded polytetrafluoroethylene grafts in a canine model. J. Vasc. Surg. 1998, 27, 902-908.
152. Rotmans, J.I.; Heyligers, J.M.; Stroes, E.S.; Pasterkamp, G. Endothelial progenitor cell-seeded grafts: Rash and risky. Can. J. Cardiol. 2006, 22, 1113-1116. (Pubitemid 44932377)
153. Reing, J.E.; Zhang, L.; Myers-Irvin, J.; Cordero, K.E.; Freytes, D.O.; Heber-Katz, E.; Bedelbaeva, K.; McIntosh, D.; Dewilde, A.; Braunhut, S.J.; Badylak, S.F. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng. Part A 2009, 15, 605-614.
154. Brennan, E.P.; Tang, X.H.; Stewart-Akers, A.M.; Gudas, L.J.; Badylak, S.F. Chemoattractant activity of degradation products of fetal and adult skin extracellular matrix for keratinocyte progenitor cells. J. Tissue Eng. Regen Med. 2008, 2, 491-498.
155. de Mel, A.; Jell, G.; Stevens, M.M.; Seifalian, A.M. Biofunctionalization of biomaterials for accelerated in situ endothelialization: A review. Biomacromolecules 2008, 9, 2969-2979.
156. Prasad, C.K.; Krishnan, L.K. Regulation of endothelial cell phenotype by biomimetic matrix coated on biomaterials for cardiovascular tissue engineering. Acta Biomater. 2008, 4, 182-191.
157. Alobaid, N.; Salacinski, H.J.; Sales, K.M.; Ramesh, B.; Kannan, R.Y.; Hamilton,G.; Seifalian, A.M. Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells: An in vitro evaluation. Eur. J. Vasc. Endovasc. Surg. 2006, 32, 76-83.
158. Wijelath, E.; Rahman, S.; Murray, J.; Patel, Y.; Savidge, G.; Sobel, M. Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial
159. Schneider, A.; Chandra, M.; Lazarovici, G.; Vlodavsky, I.; Merin, G.; Uretzky, G.; Borman,J.B.; Schwalb, H. Naturally produced extracellular matrix is an excellent substrate for canine endothelial cell proliferation and resistance to shear stress on PTFE vascular grafts. Thromb. Haemost. 1997, 78, 1392-1398. (Pubitemid 27491316)
160. Pollara, P., Alessandri, G., Bonardelli, S., Simonini, A., Cabibbo, E., Portolani, N., Tiberio, G.A., Giulini, S.M., Turano, A. Complete in vitro prosthesis endothelialization induced by artificial extracellular matrix. J. Invest. Surg. 1999, 12, 81-88. (Pubitemid 29182423)
161. Temple, W.J.; Voitk, A.J.; Snelling, C.F.; Crispin, J.S. Effect of nutrition, diet and suture material on long term wound healing. Ann. Surg. 1975, 182, 93-97.
162. Say, J. The metabolic changes associated with trauma and sepsis. Nurs. Crit. Care 1997, 2, 83-87.
163. Wilmore, D.W. Metabolic response to severe surgical illness: Overview. World J. Surg. 2000, 24, 705-711. (Pubitemid 30331846)
164. Williams, J.; Barbul, A. Nutrition and wound healing. Surg. Clin. North Am. 2003, 83, 71-96.
165. Demling, R. Anticatabolic and anabolic strategies in critical illness. Shock 1998, 10, 155-160.
166. MacKay, P.; Miller, J. Nutritional support for wound healing. Altern. Med. Rev. 2003, 8, 359-362.
167. Demling, R. H. Nutrition, anabolism, and the wound healing process: An overview. Eplasty 2009, e9, 65-94.
168. Trujillo, E.B. Effects of nutritional status on wound healing. J. Vasc. Nurs. 1993, 11, 12-18.
169. Kiyama, T.; Witte, M.B.; Thornton, F.J.; Barbul, A. The route of nutrition support affects the early phase of wound healing. J. Parenter. Enter. Nutr. 1998, 22, 276-279. (Pubitemid 28406838)
170. Stotts, N.A.; Washington, D.F. Nutrition: A critical component of wound healing. AACN Clin. Issues Crit. Care Nurs. 1990, 1, 585-594.
171. Wray, C.; Mammen, J.; Hasselgren, P. Catabolic response to stress and potential benefits of nutritional support. Nutrition 2002, 18, 971-977. (Pubitemid 35304809)
172. Swinburn, B.A.; Ravussin, E. Energy and macronutrient metabolism. Clin. Endocrinol. Metab. 1994, 8, 527-548.
173. Salacinski, H.J.; Goldner, S.; Giudiceandrea, A.; Hamilton, G.; Seifalian, A.M.; Edwards, A, Carson, R.J. The Mechanical Behaviour of Vascular Grafts: A Review. J. Biomater. Appl. 2001, 15, 241-278. (Pubitemid 32286553)
174. Haruguchi, H.; Teraoka, S. Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: A review. J. Artif. Organs. 2003, 6, 227-235. (Pubitemid 38031314)
175. Arndt, J.O.; Klauski, J.; Hersch, F. The diameter of the intact carotid artery in man. Pfluegers Arch. 1968, 301, 230-240.
176. Patel, D.F.; Greenfield, J.C.; Fry, D.L. In vitro pressure-length-radius relationships of certain blood vessels in man and dog. In Pulsatile Blood Flow; Attinger, E.O., Ed.; Blahiston-McGraw Hill: New York, NY, USA, 1963, pp. 293-305.
177. Roeder, R.; Wolfe, J.; Lianakis, N.; Hinson, T.; Geddes, L.A.; Obermiller, J. Compliance, elastic modulus and burst pressure of small-intestine submucosa (SIS), small-diameter vascular grafts. J. Biomed. Mater. Res. 1999, 47, 65-70.
178. Jacot, J.G.; Abdullah, I.; Belkin, M.; Gerhard-Herman, M.; Gaccione, P.; Polak, J.F.; Donaldson, M.C.; Whittemore, A.D.; Conte, M.S. Early adaptation of human lower extremity vein grafts: Wall stiffness changes accompany geometric remodeling. J. Vasc. Surg. 2004, 39, 547-555.
179. Sawyer, P.N. Modern Vascular Grafts; McGraw-Hill, Inc.: New York, NY, USA, 1987; p. 326.
180. Hasegawa, M.; Azuma, T. Mechanical properties of synthetic arterial grafts. J. Biomech. 1979, 12, 509-517. (Pubitemid 10224924)
181. Stewart, S.F.C.; Lyman, D.J. Essential physical characteristics of vascular grafts. In Modern Vascular Grafts; Sawyer, P.N., Ed.; McGraw-Hill, Inc.: New York, NY, USA, 1987; pp. 117-121.
182. Freytes, D.O.; Badylak, S.F.; Webster, T.J.; Geddes, L.A.; Rundell, A.E. Biaxial strength of multilaminated extracellular matrix scaffolds. Biomaterials 2004, 25, 2353-2361.
183. Herbert, S.T.; Badylak, S.F.; Geddes, L.A.; Hillberry, B.; Lantz, G.C.; Kokini, K. Elastic modulus of prepared canine jejenum, a new vascular graft material. Ann. Biomed. Eng. 1993, 21, 727-733. (Pubitemid 24026389)
184. Freytes, D.O.; Stoner, R.M.; Badylak, S.F. Uniaxial and biaxial properties of terminally sterilized porcine urinary bladder matrix scaffolds. Mater. Res. Part B: Appl. Biomater. 2008, 84B, 408-414.
185. Callanan, A.; Biggins, E.M.; Badylak, S.F.; McGloughlin, T.M. The influence of endothelial cell attachment to UBM extracellular matrix on the regulation of matrix metalloproteinase's (MMP's) and degradation. In Proceedings of Biologic Scaffolds for Regenerative Medicine; - Arizona Symposium February 15-16th, Phoenix, AZ, USA, 2008.
186. Roeder, R.A.; Lantz G.C.; Geddes L.A. Mechanical remodeling of small-intestine submicosa small-diameter vascular graft-A preliminary report. Biomed. Instrum. Technol. 2001, 35, 110-120.
187. Grimes, M.; Pembroke, J.T.; McGloughlin, T.M. The effect of choice of sterilisation method on the biocompatibility and biodegradability of SIS (Small Intestinal Submucosa). Bio.-Med. Mater. Eng. 2005, 15, 65-71.
188. O'Brien, TP.; Grace, P.; Walsh, M.; Burke, P.; McGloughlin, T. Computational investigations of a new prosthetic femoral-popliteal bypass graft design. J. Vasc. Surg. 2005, 42, 1169-1175. (Pubitemid 41817174)
189. Rickard, R.F.; Meyer, C.; Hudson, D.A. Computational modeling of microarterial anastomoses with size discrepancy (small-to-large). J. Surg. Res. 2009, 153, 1-11.
190. Callanan, A.; Morris, L.; Badylak, S.F.; McGloughlin, T.M. MMP and VEGF regulation in endothelial cell-seeded UBM extracellular matrix in a bioreactor. In Proceeding of European Society of Biomechanics (ESB), Lucerne, Switzerland, 6-9 July, 2008.
191. Mitsuoka, H.; Kitamura, S.; Kuwahara, K.; Unno, N. Impact of in vivo ranges of the variances in the flow velocity waveforms and flow split ratio on the hemodynamic effects of the anastomotic cuff at distal end-to-side anastomosis. Surg. Today 2006, 36, 769-774. (Pubitemid 44306188)
192. Longest, P.W.; Kleinstreuer, C. Numerical simulation of wall shear stress conditions and platelet localization in realistic end-to-side arterial anastomoses. J .Biomech. Eng. 2003, 125, 671-681. (Pubitemid 37315336)
193. Noori, N.; Scherer, R.; Perktold, K.; Czerny, M.; Karner, G.; Trubel, M.; Polterauer, P.; Schima, H. Blood flow in distal end-to-side anastomoses with PTFE and a venous patch: Results of an in vitro flow visualisation study. Eur. J. Vasc. Endovasc. Surg. 1999, 18, 191-200. (Pubitemid 29431342)
194. Lei, M.; Archie, J.P.; Kleinstreuer, C. Computational design of a bypass graft that minimizes wall shear stress gradients in the region of the distal anastomosis. J. Vasc. Surg. 1997, 25, 637-646. (Pubitemid 27190926)
195. Hofer, M.; Rappitsch, G.; Perktold, K.; Trubel, W.; Schima, H. Numerical study of wall mechanics and fluid dynamics in end-to-side anastomoses and correlation to intimal hyperplasia. J. Biomech. 1996, 29, 1297-1308. (Pubitemid 26302375)
196. Zhang, L.; Moskovitz, M.; Piscatelli, S.; Longaker, M.T.; Siebert, J.W. Hemodynamic study of different angled end-to-side anastomoses. Microsurgery 1995, 16, 114-117.
197. Migliavacca, F.; Dubini, G. Computational modeling of vascular anastomoses. Biomech. Model. Mechanobiol. 2005, 3, 235-250.
198. Jackson, M.J.; Bicknell, C.D.; Zervas, V.; Cheshire, N.J.; Sherwin, S.J.; Giordana, S.; Peiró, J.; Papaharilaou, Y.; Doorly, D.J.; Caro, C.G. Three-dimensional reconstruction of autologous vein bypass graft distal anastomoses imaged with magnetic resonance: Clinical and research applications. J. Vasc. Surg. 2003, 38, 621-625. (Pubitemid 41123237)
199. Rickard, R.F.; Meyer, C.; Hudson, D.A. Computational modeling of microarterial anastomoses with size discrepancy (small-to-large). J. Surg. Res. 2009, 153, 1-11.
200. Willis, D.J.; Kalish, J.A.; Li, C.; Deutsch, E.R.; Contreras, M.A.; LoGerfo, F.W.; Quist, W.C. Temporal gene expression following prosthetic arterial grafting, J. Surg. Res. 2004, 120, 27-36.
201. Geary, R.L.; Wong, J.M.; Rossini, A.; Schwartz, S.M.; Adams, L.D. Expression profiling identifies 147 genes contributing to a unique primate neointimal smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 2010-2016.
202. Orr, A.W.; Ginsberg, M.H.; Shattil, S.J.; Deckmyn, H.; Schwartz, M.A. Matrix-specific suppression of integrin activation in shear stress signaling. Mol. Biol. Cell 2006, 17, 4686-4697.
203. Jalali, S.; del Pozo, M.A.; Chen, K.D.; Miao, H.; Li, Y.S.; Schwartz, M.A.; Shyy, J.Y.; Chien, S. Integrin-mediated mechanotransduction requires its dynamic interaction with specific extracellular matrix (ECM) ligands. Proc. Natl. Acad. Sci. USA 2001, 98, 1042-1046. (Pubitemid 32121183)
204. Shyy, J.Y.J.; Chien, S. Role of integrins in endothelial mechanosensing of shear stress. Circ. Res. 2002, 91, 769-775. (Pubitemid 35285073)
205. Li, S.; Huang, N.F.; Hsu, S. Mechanotransduction in endothelial cell migration. J. Cell Biochem. 2005, 96, 1110-1126.
206. Senger, D.R.; Claffey, K.P.; Benes, J.E.; Perruzzi, C.A.; Sergiou, A.P.; Detmar, M. Angiogenesis promoted by vascular endothelial growth factor: Regulation through á1â1 and á2â1 integrins. Proc. Natl. Acad. Sci. USA 1997, 94, 13612-13617.
207. Davis, G.; Black, S.; Bayless, K. Capillary morphogenesis during human endothelial cell invasion of three-dimensional collagen matrices. In vitro Cell Dev. Biol. An. 2000, 36, 513-519.
208. Davis, G.E.; Bayless, K.J.; Mavila, A. Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat. Record 2002, 268, 252-275. (Pubitemid 35246845)
209. Sonnenberg, A.; Modderman, P.W.; Hogervorst, F. Laminin receptor on platelets is the integrin VLA-6. Nature 1988, 336, 487-489. (Pubitemid 18274538)
210. Lim, L.; Manser, E.; Leung, T.; Hall, C. Regulation of phosphorylation pathways by p21 GTPases: The p21 Ras-related Rho subfamily and its role in phosphorylation signaling pathways. Eur. J. Biochem. 1996, 242, 171-185. (Pubitemid 26414218)
211. Monick, M.M.; Powers, L.; Butler, N.; Yarovinsky, T.; Hunninghake, G.W. Interaction of matrix with integrin receptors is required for optimal LPS-induced MAP kinase activation. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 283, 390-402.
212. Akimoto, S.; Mitsumata, M.; Sasaguri, T.; Yoshida, Y. Laminar shear stress inhibits vascular endothelial cell proliferation by inducing cyclin-dependent kinase inhibitor p21Sdi1/Cip1/Waf1. Circ. Res. 2000, 86, 185-190. (Pubitemid 30086179)
213. Lin, K.; Hsu, P.P.; Chen, B.P.; Yuan, S.; Usami, S.; Shyy, J.Y.J.; Li, Y.S.; Chien, S. Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc. Natl. Acad. Sci. USA 2000, 97, 9385-9389. (Pubitemid 30650784)
214. Nagel, T.; Resnick, N.; Dewey, C.F.; Jr.; Gimbrone, M.A., Jr. Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 1825-1834.
215. Chiu, J.J.; Chen, L.J.; Chang, S.F.; Lee, P.L.; Lee, C.I.; Tsai, M.C.; Lee, D.Y.; Hsieh, H.P.; Usami, S.; Chien, S. Shear stress inhibits smooth muscle cell-induced inflammatory gene expression in endothelial cells: Role of NF-{kappa}B. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 963-969. (Pubitemid 40627840)
216. Cenni, E.; Granchi, D.; Verri, E.; Remiddi, G.; Cavedagna, D.; Di Leo, A. Evaluation of endothelial cell integrins after in vitro contact with polyethylene terephthalate. J. Mater. Sci.- Mater. M. 2001, 12, 345-349. (Pubitemid 32467588)
217. Pu, F.R.; Williams, R.L.; Markkula, T.K.; Hunt, J.A. Effects of plasma treated PET and PTFE on expression of adhesion molecules by human endothelial cells in vitro. Biomaterials 2002, 23, 2411-2428. (Pubitemid 34234843)
218. van der Zijpp, Y.J.; Poot, A.A.; Feijen, J. ICAM-1 and VCAM-1 expression by endothelial cells grown on fibronectin-coated TCPS and PS. J. Biomed. Mater. Res. A 2003, 65, 51-59. (Pubitemid 37517285)
219. O'Keeffe, L.M.; Muir, G.; Piterina, A.V.; McGloughlin, T.M. Vascular cell adhesion molecule-1 expression in endothelial cells exposed to physiological coronary wall shear stresses. J. Biomech. Eng.-T. ASME 2009, 131, 081003-081009.
220. Aro, H. Effect of nerve injury on fracture healing. Callus formation studied in the rat. Acta Orthop. Scand. 1985, 56, 233-237. (Pubitemid 16246536)
221. Lambiase, A.; Manni, L.; Bonini, S.; Rama, P.; Micera, A.; Aloe, L. Nerve growth factor promotes corneal healing: Structural, biochemical, and molecular analyses of rat and human corneas. Invest. Ophthalmol. Vis. Sci. 2000, 41, 1063-1069. (Pubitemid 30187542)
222. Cowen, T.; Burnstock, G. Quantitative analysis of the density and pattern of adrenergic innervation of blood vessels. A new method. Histochemistry 1980, 66, 19-34. (Pubitemid 10090814)
223. Crick, S.J.; Wharton, J.; Sheppard, M.N.; Royston, D.; Yacoub, M.H.; Anderson, R.H.; Polak, J.M. Innervation of the human cardiac conduction system. A quantitative immunohistochemical and histochemical study. Circulation 1994, 89, 1697-11670
224. Cowen, T.; MacCormick, D.E.M.; Toff, W.D.; Burnstock, G.; Lumley, J.S.P. The effect of surgical procedures on blood vessel innervation a fluorescence histochemical study of degeneration and regrowth of perivascular adrenergic nerves. Blood Vessels 1982, 19, 65-78.
225. Head, R.J. Hypernoradrenergic innervation and vascular smooth muscle hyperplastic change. Blood Vessels 1991, 28, 173-178.
226. Autiero, M.; De Smet, F.; Claes, F.; Carmeliet, P. Role of neural guidance signals in blood vessel navigation. Cardiovasc. Res. 2005, 65, 629-638. (Pubitemid 40138983)
227. Carmeliet, P.; Tessier-Lavigne, M. Common mechanisms of nerve and blood vessel wiring. Nature 2005, 436, 193-200. (Pubitemid 41021263)
228. Raab, S.; Plate, K.H. Different networks, common growth factors: Shared growth factors and receptors of the vascular and the nervous system. Acta Neuropathol. 2007, 113, 607-626.
229. Yoshida, K.; Okamura, T.; Kimura, H.; Bredt, D.S.; Snyder, S.H.; Toda, N. Nitric oxide synthase-immunoreactive nerve fibers in dog cerebral and peripheral arteries. Brain Res. 1993, 629, 67-72. (Pubitemid 23328787)
230. Auger, F.A.; D'Orléans-Juste, P.; Germain, L. Adventitia contribution to vascular contraction: Hints provided by tissue-engineered substitutes. Cardiovasc. Res. 2007, 75, 669-678. (Pubitemid 47238741)
231. Gutterman, D.D. Adventitia-dependent influences on vascular function. Am. J. Physiol. 1999, 277, 1265-1272.
232. van Brummelen, P.; Jie, K.; van Zwieten, P.A. Alpha-adrenergic receptors in human blood vessels. Br. J. Clin. Pharmacol. 1986, 21, 33-39.
233. Vanhoutte, P.M. Endothelial adrenoceptors. J. Cardiovasc. Pharm. 2001, 38, 796-808.
234. Tsuru, H.; Tanimitsu, N.; Hirai, T. Role of perivascular sympathetic nerves and regional differences in the features of sympathetic innervation of the vascular system. Jpn. J. Pharmacol. 2002, 88, 9-13. (Pubitemid 34139832)
235. Tsuru, H. The diversity of autonomic innervation in the vascular system. Autonomic Nervous System 1999, 36, 119-125.
236. Bevan, J.A. Some bases of differences in vascular response to sympathetic activity. Circ. Res. 1979, 45, 161-171.
237. Bevan, R.D.; Clementson, A.; Joyce, E.; Bevan, J.A. Sympathetic denervation of resistance arteries increases contraction and decreases relaxation to flow. Am. J. Physiol. Heart Circ. Physiol. 1993, 264, 490-494.
238. Meagher, S.; McGeachie, J.; Prendergast, F. Vein to artery grafts. An experimental study of reinnervation of the graft wall. Ann. Surg. 1984, 200, 153-158. (Pubitemid 14059592)
239. Hoch, J.R.; Stark, V.K.; Turnipseed, W.D. The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression. J. Vasc. Surg. 1995, 22, 51-58.
240. Reuthebuch, O.T.; Kadner, A.; Lachat, M.L.; Turina, M.I. Graft occlusion after deployment of the symmetry bypass system. Ann. Thorac. Surg. 2003, 75, 1626-1629. (Pubitemid 36515256)
241. Alimi, Y.; Juhan, C.; Morati, N.; Girard, N.; Cohen, S. Dilation of woven and knitted aortic prosthetic grafts: CT scan evaluation. Ann. Vasc. Surg. 1994, 8, 238-242. (Pubitemid 24164860)
242. Kropp, B.P.; Sawyer, B.D.; Shannon, H.E.; Rippy, M.K.; Badylak, S.F.; Adams, M.C.; Keating, M.A.; Rink, R.C.; Thor, K.B. Characterization of small intestinal submucosa regenerated canine detrusor: assessment of reinnervation, in vitro compliance and contractility. J. Urol. 1996, 156, 599-607.
243. Kropp, B.P.; Rippy, M.K.; Badylak, S.F.; Adams, M.C.; Keating, M.A.; Rink, R.C.; Thor, K.B. Regenerative urinary bladder augmentation using small intestinal submucosa: Urodynamic and histopathologic assessment in long-term canine bladder augmentations. J. Urol. 1996, 155, 2098-2104.
244. Vaught, J.D.; Kropp, B.P.; Sawyer, B.D.; Rippy, M.K.; Badylak, S.F.; Shannon, H.E.; Thor, K.B. Detrusor regeneration in the rat using porcine small intestinal submucosal grafts: Functional innervation and receptor expression. J. Urol. 1996, 155, 374-378.
245. Ciardelli, G.; Chiono, V. Materials for peripheral nerve regeneration. Macromol. Biosci. 2006, 6, 13-26.
246. Crouzier, T.; McClendon, T.; Tosun, Z.; McFetridge, P.S. Inverted human umbilical arteries with tunable wall thicknesses for nerve regeneration. J. Biomed. Mater. Res. A 2009, 89, 818-828.
247. Hadlock, T.A.; Sundback, C.A.; Hunter, D.A.; Vacanti, J.P.; Cheney, M.L. A new artificial nerve graft containing rolled Schwann cell monolayers. Microsurgery 2001, 21, 96-101. (Pubitemid 32522196)
248. Su, Y.; Zeng, B.F.; Zhang, C.Q.; Zhang, K.G.; Xie, X.T. Study of biocompatibility of small intestinal submucosa (SIS) with Schwann cells in vitro. Brain Res. 2007, 11, 41-47. (Pubitemid 46497977)
249. Aumailley, M.; El Khal, A.; Knöss, N.; Tunggal, L. Laminin 5 processing and its integration into the ECM. Matrix Biol. 2003, 22, 49-54. (Pubitemid 36444506)
250. Armstrong, S.J.; Wiberg, M.; Terenghi, G.; Kingham, P.J. ECM molecules mediate both Schwann cell proliferation and activation to enhance neurite outgrowth. Tissue Eng. 2007, 13, 2863-2870.
251. Matesz, C.; Modis, L.; Halasi, G.; Szigeti, Z.M.; Felszeghy, S.; Bacskai, T.; Szekely, G. Extracellular matrix molecules and their possible roles in the regeneration of frog nervous system. Brain Res. Bull. 2005, 66, 526-531. (Pubitemid 41247707)
252. Ranieri, J.P.; Bellamkonda, R.; Bekos, E.J.; Gardella, J.A., Jr.; Mathieu, H.J.; Ruiz, L.; Aebischer, P. Spatial control of neuronal cell attachment and differentiation on covalently patterned laminin oligopeptide substrates. Int. J. Dev. Neurosci. 1994, 12, 725-735.
253. Reichardt, L.F.; Tomaselli, K.J. Extracellular matrix molecules and their receptors: Functions in neural development. Annu. Rev. Neurosci. 1991, 14, 531-570.
254. McFetridge, P.S.; Daniel, J.W.; Bodamyali, T.; Horrocks, M.; Chaudhuri, J.B. Preparation of porcine carotid arteries for vascular tissue engineering applications. J. Biomed. Mater. Res. A 2004, 70, 224-234.
255. Grauss, R.W.; Hazekamp, M.G.; Oppenhuizen, F.; van Munsteren, C.J.; Gittenberger-de Groot, A.C.; DeRuiter, M.C. Histological evaluation of decellularised porcine aortic valves: Matrix changes due to different decellularisation methods. Eur. J. Cardiothorac Surg. 2005, 27, 566-571.
256. Schenke-Layland, K.; Vasilevski, O.; Opitz, F.; König, K.; Riemann, I.; Halbhuber, K.J.; Wahlers, T.H.; Stock, U.A. Impact of decellularisation of xenogenetic tissue on extracellular matrix integrity for tissue engineering of heart valves. J. Struct. Biol. 2003, 143, 201-208. (Pubitemid 37297860)
257. Spark, J.I.; Yeluri, S.; Derham, C.; Wong, Y.T.; Leitch, D. Incomplete cellular depopulation may explain the high failure rate of bovine ureteric grafts. Br. J. Surg. 2008, 95, 582-585.
258. Gratzer, P.F.; Harrison, R.D.; Woods, T. Matrix alteration and not residual sodium dodecyl sulfate cytotoxicity affects the cellular repopulation of a decellularized matrix. Tissue Eng. 2006, 12, 2975-2983. (Pubitemid 46141262)
259. Korossis, S.A.; Wilcox, H.E.; Watterson, K.G.; Kearney, J.N.; Ingham, E.; Fisher, J. In-vitro assessment of the functional performance of the decellularized intact porcineaortic root. J. Heart Valve Dis. 2005, 14, 408-421. (Pubitemid 47050756)
260. Gilbert, T.W.; Freund, J.M.; Badylak, S.F. Quantification of DNA in biologic scaffold materials. J. Surg. Res. 2008, 152, 135-139.
261. Daly, K.; Stewart-Akers, A.; Hara, H.; Ezzelarab, M.; Long, C.; Cordero, K.; Johnson, S.; Ayares, D.; Cooper, D.; Badylak, S.F. Effect of the áGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model. Tissue Eng. Part A 2009, in press.
262. Seebacher, G.; Grasl, C.; Stoiber, M.; Rieder, E.; Kasimir, M.T.; Dunkler, D.; Simon, P.; Weigel, G.; Schima, H. Biomechanical properties of decellularized porcine pulmonary valve conduits. Artif. Organs 2008, 32, 28-35.
263. Herijgers, P.; Ozaki, S.; Verbeken, E.; van Lommel, A.; Ràcz, R.; Zietkiewicz, M.; Perek, .B; Flameng, W. Calcification characteristics of porcine stentless valves injuvenile sheep. Eur. J. Cardiothorac Surg. 1999, 15, 134-142. (Pubitemid 29156779)
264. Hopkins, R.A.; Jones, A.L.; Wolfinbarger, L.; Moore, M.A.; Bert, A.A.; Lofland, G.K. Decellularization reduces calcification while improving both durability and 1-year functional results of pulmonary homograft valves in juvenile sheep. J. Thorac. Cardiovasc. Surg. 2009, 137, 907-913.
265. Woods, A.M.; Rodenberg, E.J.; Hiles, M.C.; Pavalko, F.M. Improved biocompatibility of small intestinal submucosa (SIS) following conditioning by human endothelial cells. Biomaterials 2004, 25, 515-525.
266. Ball, P. Natural strategies for the molecular engineer. Nanotechnology 2002, 13, 15-28.
267. Hu, L.; Hu, Z.; Wang, S. Progress in genetic modification of vascular prostheses and its significance in molecular reconstruction. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008, 22, 1501-1504.
268. Baker, A.H. Designing gene delivery vectors for cardiovascular gene therapy. Prog. Biophys. Mol. Biol. 2004, 84, 279-299. (Pubitemid 38215216)
269. Hay, C.M.; De Leon, H.; Jafari, J.D.; Jakubczak, J.L.; Mech, C.A.; Hallenbeck, P.L.; Powell, S.K.; Liau, G.; Stevenson, S.C. Enhanced gene transfer to rabbit jugular veins by an adenovirus containing a cyclic RGD motif in the HI loop of the fiber knob. J. Vasc. Res. 2001, 38, 315-323.
270. Tiera, M.J.; Winnik, F.O.; Fernandes, J.C. Synthetic and natural polycations for gene therapy: State of the art and new perspectives. Curr. Gene. Ther. 2006, 6, 59-71.
271. Li, J.M.; Collins, L.; Zhang, X.; Gustafsson, K.; Fabre, J.W. Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: A first step toward the gene therapy of chronic rejection. Transplantation 2000, 70, 1616-1624. (Pubitemid 32037976)
272. Corchero, J.L.; Villaverde, A. Biomedical applications of distally controlled magnetic nanoparticles. Trends Biotechnol. 2009, 8, 468-476.
273. Zhao, X.; Pan, F.; Holt, C.M.; Lewis, A.L.; Lu, J.R. Controlled delivery of antisense oligonucleotides: A brief review of current strategies. Expert Opin. Drug Deliv. 2009, 6, 673-686.
274. Xu, G.; Zhang, N. Nanoparticles for gene delivery: A brief patent review. Recent Pat. Drug Deliv. Formul. 2009, 3, 125-136.
275. Nam, H.Y.; Park, J.H.; Kim, K.; Kwon, I.C.; Jeong, S.Y. Lipid-based emulsion system as nonviral gene carriers. Arch. Pharm. Res. 2009, 32, 639-646.
276. Singh, R.; Kostarelos, K. Designer adenoviruses for nanomedicine and nanodiagnostics. Trends Biotechnol. 2009, 27, 220-229.
277. Paleos, C.M.; Tziveleka, L.A.; Sideratou, Z.; Tsiourvas, D. Gene delivery using functional dendritic polymers. Expert Opin. Drug Deliv. 2009, 6, 27-38.
278. Glickson, J.D.; Lund-Katz, S.; Zhou, R.; Choi, H.; Chen, I.W.; Li, H.; Corbin, I.; Popov, A.V.; Cao, W.; Song, L.; Qi, C.; Marotta, D.; Nelson, D.S.; Chen, J.; Chance, B.; Zheng, G. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents. Adv. Exp. Med. Biol. 2009, 645, 227-239.
279. Wang, V.; Wu, W. MicroRNA-based therapeutics for cancer. BioDrugs 2009, 23, 15-23.
280. Mykhaylyk, O.; Zelphati, O.; Hammerschmid, E.; Anton, M.; Rosenecker, J.; Plank, C. Recent advances in magnetofection and its potential to deliver siRNAs in vitro. Methods Mol. Biol. 2009, 487, 111-146.
281. Stone, P.J.; Morris, S.M.; Griffin, S.; Mithieux, S.; Weiss, A.S. Building Elastin. Incorporation of recombinant human tropoelastin into extracellular matrices using nonelastogenic rat-1 fibroblasts as a source for lysyl oxidase. Am. J. Respir. Cell Mol. Biol. 2001, 24, 733-739.
282. Kallenbach, K.; Salcher, R.; Heim, A.; Karck, M.; Mignatti, P.; Haverich, A. Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3. J. Vasc. Surg. 2009, 49, 750-758.
283. Li, S.F.; Meng, Q.H.; Yao, W.C.; Hu, G.J.; Li, G.L.; Li, Z.J.; Wei, J.J.; Bo, Y.L.; Zhang, Z.H.; Wang, R.Z. Recombinant AAV1 mediated vascular endothelial growth factor gene expression promotes angiogenesis and improves neural function: Experiment with rats. Zhonghua Yi Xue Za Zhi 2009, 89, 167-170.
284. Callanan, A.; Morris, L.; McGIoughlin, T.M.; Gilbert, T.W.; Badylak, S.F. Regulation of MMP's in endothelial cell-seeded UBM extracellular matrix under shear. In Proceedings of the Tissue Engineering Regenerative Medicine International Society (TERMIS) EU Chapter Meeting, London, UK, September 4-7, 2007.
285. Gilbert, T.W.; Stewart-Akers, A.M.; Sydeski, J.; Nguyen, T.D.; Badylak, S.F.; Woo, S.L.Y. Gene expression by fibroblasts seeded on small intestinal submucosa and subjected to cyclic stretching. Tissue Eng. 2007, 13, 1313-1323.
286. Shaikh, F.M.; O'Brien, T.P.; Callanan, A.; Kavanagh, E.G.; Burke, P.E.; Grace, P.A.; McGloughlin, T.M. New pulsatile hydrostatic pressure bioreactor for vascular tissue-engineered constructs. Artif. Organs 2009, in press.
287. Isenberg, B.C.; Williams, C.; Tranquillo, R.T. Small-diameter Artificial arteries engineered in vitro. Circ. Res. 2006, 98, 25-35.
288. Stankus, J.J.; Freytes, D.O.; Badylak, S.F.; Wagner, W.R. Hybrid nanofibrous scaffolds from electrospinning of a synthetic biodegradable elastomer and urinary bladder matrix. J. Biomater.Sci. Polym. Ed. 2008, 19, 635-652.
289. Courtney, T.; Sacks, M.S.; Stankus, J.; Guan, J.; Wagner, W.R. Design and analysis of tissue engineering scaffolds that mimic soft tissue mechanical anisotropy. Biomaterials 2006, 27, 3631-3638.
290. Freytes, D.O.; Rundell, A.E.; vande Geest, J.; Vorp, D.A.; Webster, T.J.; Badylak, S.F. Analytically derived material properties of multilaminated extracellular matrix devices using the ball-burst test. Biomaterials 2005, 26, 5518-5531.
291. Zeugolis, D.I.; Khew, S.T.; Yew, E.S.Y.; Ekaputra, A.K.; Tong, Y.W.; Yung, L.-Y.L.; Hutmacher, D.W.; Sheppard, C.; Raghunath, M. Electro-spinning of pure collagen nano-fibres- Just an expensive way to make gelatin. Biomaterials 2008, 29, 2293-2305.
292. Min, L.; Paul, C.Y.C.; James, C.Y.D. Evaluation of small intestinal submucosa as scaffoldsfor intestinal tissue engineering. J. Surg. Res. 2008, 147, 168-171.
293. Lutolf, M.P.; Hubbell, J.A. Synthetic biomaterials as cell-responsive artificial extracellular matrices. In Advances in Tissue Engineering, 2nd ed.; Polak, J., Mantalaris, S., Harding, S.E., Eds.; Imperial College Press: London, UK, 2007, pp. 154-196.
294. Ruoslahti, E.; Reed, J. Cell adhesion: New way to activate caspases. Nature 1999, 397, 479-480.
295. Lauer-Fields, J.; Nagase, H.; Fields, G. Selective hydrolysis of triple-helical peptides by matrix metalloproteinases. In Peptides for the New Millennium; Kluwer Academic Publisher, Springer: New York, NY, USA, 2000; pp. 342-343.
296. Zhang, Y.; He, Y.; Bharadwaj, S.; Hammam, N.; Carnagey, K.; Myers, R.; Atala, A.; van Dyke, M. Tissue-specific extracellular matrix coatings for the promotion of cell proliferation and maintenance of cell phenotype. Biomaterials 2009, 30, 4021-4028.
297. Thomas, A.C.; Campbell, G.R; Campbell, J.H. Advances in vascular tissue engineering. Cardiovasc. Pathol. 2003, 12, 271-276.
298. Swartz, D.D.; Russell, J.A.; Andreadis, S.T. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, 1451-1460.
299. Lamm, P.; Adelhard, K.; Juchem, G.; Weitkunatb, R.; Milzc, S.; Kilgerd, E.; Gotzd, A.; Reicharta, B. Fibrin glue in coronary artery bypass grafting operations: Casting out the Devil with Beelzebub? Eur. J. Cardiothorac Surg. 2007, 32, 567-572.
300. Aldenhoff, Y.B.; van Der Veen, F.H.; ter Woorst, J. Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin) coating on its lumenal surface. J. Biomed. Mater. Res. 2001, 54, 224-233.
301. Walpoth, B.H.; Rogulenko, R.; Tikhvinskaia, E.; Gogolewski, S., Schaffner, T.; Hess, O.M.; Althaus, U. Improvement of patency rate in heparin-coated small synthetic vascular grafts. Circulation 1998, 98, 319-323. (Pubitemid 28512206)
302. Nerem, R.M.; Seliktar, D. Vascular tissue engineering. Annu. Rev. Biomed. Eng. 2001, 3, 225-243.
303. Stitzel, J.; Liu, J.; Lee, S.J.; Komura, M.; Berry, J.; Soker, S.; Lim, G.; van Dyke, M.; Czerw, R.; Yoo, J.J.; Atala, A. Controlled fabrication of a biological vascular substitute. Biomaterials 2006, 27, 1088-1094. (Pubitemid 41566702)
304. Tillman, B.W.; Yazdani, S.K.; Lee, S.J.; Geary, R.L.; Atala, A.; Yoo, J.J. The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction. Biomaterials 2009, 30, 583-588.